ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Artificial Intelligence How This Biotech Startup is Using AI to Treat Neurodegenerative DiseaseBy Biotech Metropolitan WomenMarch 31, 2022Digital biotech company OccamzRazor recently raised $6.1MM in a series A funding round that closed in March 2022. The round… Read More
